WASHINGTON, Nov. 29, 2016
WASHINGTON, Nov. 29, 2016 /PRNewswire/ -- Dr. Andrew Pecora, the Founder & Executive Chairman of Cota, the leading data and technology platform for precision medicine, will present the Cota Nodal Address™ (CNA) System today in Washington, DC as a featured speaker at the "Launch Pad: Pathways to Cancer InnoVAtion" event co-hosted by the Department of Veterans Affairs and the Prostate Cancer Foundation. Dr. Pecora's talk, entitled "The Cota Nodal Address™ (CNA) System: Digitally classifying every patient's disease" will introduce a group of world-class oncology experts to Cota's innovative approach to making patient data useful for healthcare decision-making. Additionally, Dr. Pecora will participate in an invitation-only CEO roundtable event prior to the start of the main sessions, and Cota will conduct a live demonstration of its technology platform during the evening reception.
"The Department of Veterans Affairs is the largest integrated health system in the United States, and a major influence in both oncology and healthcare advancement," said Dr. Pecora. "We are excited to be able to share how the CNA System and its implementation within Cota's technology can both help improve the lives of our nation's veterans as well as support the White House Moonshot Cancer Initiative by enabling healthcare professionals to deliver precision medicine at scale."
The CNA System is a unique, patented method for classifying all patient factors, their diseases, and intended therapies into a digital code that embodies all relevant clinical factors. It ensures that all patients who are medically identical are given the same Cota Nodal Address™, and should thus have similar treatments and outcomes.
This revolutionary approach to precisely classifying and cohorting patient data is an integral part of Cota's broader technology platform, CNA Guided Care™. This platform turns raw patient data into real-world evidence and enables it to be used for healthcare decision-making with easy-to-use and powerful web-based software tools. Beginning first with oncology and now expanding into other complex diseases, Cota is helping providers, payers, and life sciences companies create a future where every patient receives the right care at the right place at the right time.
Cota is a technology platform that enables providers, payers, and life science companies using real-world evidence to make value-based decisions about diagnosing and treating complex diseases. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.
Cota's technology enriches raw medical records to create research-grade data, and joins it with a suite of analysis, visualization, and management tools. This enables providers, payers, and life sciences companies to analyze, report on, and research outcomes, costs, treatments, and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and science to help improve the lives of patients everywhere.
Phone: +1 (646) 543-2682
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cota-to-present-the-cota-nodal-address-system-at-launch-pad-pathways-to-cancer-innovation-event-hosted-by-the-department-of-veterans-affairs-and-the-prostate-cancer-foundation-in-support-of-the-white-house-moonshot-cancer-init-300369671.html
SOURCE CotaPR Newswire
Last updated on: 29/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.